Evidence map›Paper›PMID 39618538›Full record

ArticleAfrican journal of infectious diseases2025

EFFECTIVENESS OF HERBAL AND CONVENTIONAL MANAGEMENT INTERVENTIONS OF HEPATITIS B VIRUS.

Adebayo Julius John, Ibraheem Lawal Odula, Omoruyi Beauty Etinosa, Okudoh Vincent Ifeanyi

Abstract read
In one paragraph

Article in African journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adebayo Julius JohnDepartment of Economics, Lead City University, Ibadan, Nigeria.
Ibraheem Lawal OdulaBio-medicinal Research Centre, Forestry Research Institute of Ibadan, Nigeria.
Omoruyi Beauty EtinosaApplied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Bellville, South Africa.
Okudoh Vincent IfeanyiDepartment of Biotechnology and Consumer Science, Cape Peninsula University of Technology, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver inflammation caused by the Hepatitis B virus (HBV) could become chronic and unresolved if untreated. Prevention and management of the disease are through vaccination and other conventional interventions. This study evaluated the cost-effectiveness of herbal management (HM) and conventional pharmaceutical management (PM) interventions in treating HBV. Materials and Methods: A purposive sampling technique was used to administer questionnaires at the University College Hospital (UCH) and Total Healthcare Diagnostic Centre (THDC). Data collection was according to a EuroQol (EQ -5D), while descriptive and inferential analyses were performed. Results: Findings revealed a high prevalence of HBV among females from ages 26 to 50. The majority discovered their health status through free HBV tests. Other than cost-effective interventions, about 73% of cases adopted HM to manage the disease. A significant difference (P<0.00) was observed in the correlation analysis of the current health status of respondents and the intervention management adopted. correlation analysis of the current health status of respondents was significantly different (P<0.01) against the intervention management adopted (P<0.00). Conclusion: The minister of health should emphasize HBV regular screening, subsidized viral load test and free vaccination in both public and private healthcare centres.

Indexed as

conventional managementcost-effectivenessHepatitis Bphytomedicinequality-adjusted life-years (QALYs)

Identifiers

PMID39618538
PMCPMC11607790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.